IRIS
AMODIO, Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.726
AS - Asia 1.736
EU - Europa 1.187
SA - Sud America 329
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 3
Totale 6.026
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.633
SG - Singapore 946
IT - Italia 567
CN - Cina 481
BR - Brasile 269
SE - Svezia 201
GB - Regno Unito 120
VN - Vietnam 109
DE - Germania 106
CA - Canada 70
IN - India 45
FI - Finlandia 34
HK - Hong Kong 33
RO - Romania 26
BD - Bangladesh 23
PL - Polonia 19
AR - Argentina 18
NL - Olanda 18
MX - Messico 17
EU - Europa 15
JP - Giappone 14
CZ - Repubblica Ceca 13
RU - Federazione Russa 13
EC - Ecuador 12
FR - Francia 12
ID - Indonesia 12
UA - Ucraina 12
EG - Egitto 11
ES - Italia 11
CL - Cile 10
IQ - Iraq 10
IR - Iran 9
TR - Turchia 8
ZA - Sudafrica 8
PY - Paraguay 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
AT - Austria 6
LT - Lituania 6
PK - Pakistan 6
CH - Svizzera 5
GR - Grecia 5
SA - Arabia Saudita 5
YE - Yemen 5
EE - Estonia 3
IL - Israele 3
JO - Giordania 3
MY - Malesia 3
NP - Nepal 3
TN - Tunisia 3
UZ - Uzbekistan 3
AU - Australia 2
CO - Colombia 2
DK - Danimarca 2
HN - Honduras 2
KE - Kenya 2
KW - Kuwait 2
NO - Norvegia 2
PA - Panama 2
PE - Perù 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
IE - Irlanda 1
LB - Libano 1
MK - Macedonia 1
NG - Nigeria 1
NR - Nauru 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 6.026
Salva come PNG Salva come JPEG
Città #
Singapore 439
Chandler 388
Santa Clara 233
Dallas 231
Hefei 225
Lawrence 189
Princeton 189
Milan 188
Catanzaro 134
Wilmington 106
London 88
Ashburn 86
Chicago 86
Munich 83
Beijing 74
Des Moines 57
Ho Chi Minh City 53
Ottawa 47
Boardman 34
Hong Kong 33
São Paulo 31
Turku 30
Los Angeles 25
Shanghai 24
Hanoi 22
Redwood City 20
Brooklyn 19
Warsaw 18
Guangzhou 16
New York 16
San Francisco 15
Council Bluffs 14
Horia 14
Pune 14
The Dalles 14
Norwalk 13
Olomouc 12
Phoenix 12
Stockholm 12
Boston 11
Rome 11
Hanover 10
Naples 10
Redmond 10
Rio de Janeiro 10
Timisoara 10
Cosenza 9
Montreal 9
San Jose 9
Bari 8
Chennai 8
Columbus 8
Manchester 8
Ann Arbor 7
Charlotte 7
Dhaka 7
Jiaxing 7
Lamezia Terme 7
Mexico City 7
Ovada 7
San Nicola Manfredi 7
Settingiano 7
Shenzhen 7
Atlanta 6
Haiphong 6
Palermo 6
Parma 6
Reggio Calabria 6
Tokyo 6
West Jordan 6
Andover 5
Ankara 5
Augusta 5
Aversa 5
Baghdad 5
Johannesburg 5
Nanjing 5
Porto Alegre 5
Sanaa 5
Amsterdam 4
Belo Horizonte 4
Caserta 4
Curitiba 4
Hebei 4
Helsinki 4
Novokuznetsk 4
Taranto 4
Toronto 4
Xi'an 4
Abaetetuba 3
Ahmedabad 3
Amman 3
Asunción 3
Blumenau 3
Cairo 3
Campinas 3
Caracas 3
Cetraro 3
Da Nang 3
Denver 3
Totale 3.665
Salva come PNG Salva come JPEG
Nome #
miR-22 suppresses DNA ligase III addiction in multiple myeloma 90
A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine. 78
MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells 66
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer 65
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells in vitro 64
A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells 63
Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease 63
Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells 60
LNA-Gapmer Antisense Oligonucleotides Targeting the Oncogenic Lncrna MALAT1 Trigger Anti-Multiple Myeloma Activity By Proteasome Blockade 59
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 57
Molecular and clinical types of plasma cell dyscrasias are associated with distinct expression patterns of long noncoding RNAs 53
Discovery, Functional Characterization and Therapeutic Targeting of Lnc-17-92 Metabolic Signaling in Multiple Myeloma 52
Turning Stem Cells Bad: Generation of Clinically Relevant Models of Human Acute Myeloid Leukemia through Gene Delivery- or Genome Editing-Based Approaches 51
Impact of natural dietary agents on multiple myeloma prevention and treatment: molecular insights and potential for clinical translation. 51
MIR-21 SUPPRESSION IMPAIRS TH17 RELATED BONE DISEASE IN MULTIPLE MYELOMA 51
MYC-MIR-22 REGULATORY LOOP MODULATES LENALIDOMIDE ACTIVITY IN MULTIPLE MYELOMA CELLS 51
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma 51
Early Hematopoietic Zinc Finger protein (EHZF), the human homologue to Evi3, is highly expressed in primitive human hematopoietic cells 49
Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats 49
Radiation induced by-stander effect: possible RNA implication in DNA damage transmission? 48
ACTIVATION OF GPER SIGNALING AS A POTENTIAL THERAPEUTIC STRATEGY AGAINST WALDENSTROM MACROGLOBULINEMIA 48
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. 48
MiR-34a Replacement As a Novel Therapeutic Approach for Multiple Myeloma: Preclinical In Vitro and In Vivo Evidence 47
In Vitro Silencing of lncRNAs Using LNA GapmeRs 47
ZNF423: A New Player in Estrogen Receptor-Positive Breast Cancer 46
TARGETING OF DEREGULATED LNCRNA NEAT1 AFFECTS MULTIPLE MYELOMA ACTIVITY 46
Anti-MALAT1 synthetic oligonucleotides target the proteasome and exert anti-multiple myeloma activity 46
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 46
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma 45
Early hematopoietic zinc finger protein, a novel transcription co-factor with a potential role in haematopoietic homeostasis and leukaemogenesis 45
Anti-tumor Activity and Epigenetic Impact of the Polyphenol Oleacein in Multiple Myeloma 45
Oleil hydroxytyrosol (Htol) exerts anti-myeloma activity by antagonizing key survival pathways in malignant plasma cells 45
Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation 44
P21-ACTIVATED KINASE 4 (PAK4) REGULATES MULTIPLE MYELOMA (MM) CELL GROWTH AND SURVIVAL BY MODULATION OF CRITICAL TRANSCRIPTIONAL PATHWAYS: THERAPEUTIC APPLICATION OF PAK4 ALLOSTERIC INHIBITORS 44
Inhibitor of DNA binding 2 (ID2) regulates key transcriptional programs in multiple myeloma 43
ZNF423: A New Player in Estrogen Receptor-Positive Breast Cancer. 43
Contribution of PKB/AKT signaling to thyroid cancer 43
Cateslytin abrogates lipopolysaccharide-induced cardiomyocyte injury by reducing inflammation and oxidative stress through toll like receptor 4 interaction 43
CRISPR Interference (CRISPRi) and CRISPR Activation (CRISPRa) to Explore the Oncogenic lncRNA Network 43
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells 42
A Comparison of Different Sample Processing Protocols for MALDI Imaging Mass Spectrometry Analysis of Formalin-Fixed Multiple Myeloma Cells 41
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma. 41
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity. 41
Synthesis and preliminary evaluation of the anti-cancer activity on A549 lung cancer cells of a series of unsaturated disulfides. 41
Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment 41
MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment 41
Activation of the Non-Canonical Estrogen Receptor Gper As a Novel Therapeutic Strategy Against Waldenstrom Macroglobulinemia 41
Znf521 enhances mll‐af9‐dependent hematopoietic stem cell transformation in acute myeloid leukemias by altering the gene expression landscape† 41
In Vitro and in Vivo Anti-tumor Activity of miR-221/222 Inhibitors in Multiple Myeloma 39
Alternative non-homologous end joining DNA repair as therapeutic target in multiple myeloma 39
A 13 mer LNA miR-221 inhibitor restores drug sensitivity in melphalan-refractory multiple myeloma cells 39
A MIR17HG-derived Long Noncoding RNA Provides an Essential Chromatin Scaffold for Protein Interaction and Myeloma Growth 38
Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma 38
Zinc finger protein 521 antagonizes early B-cell factor 1 and modulates the B-lymphoid differentiation of primary hematopoietic progenitors 38
Early hematopoietic zinc finger protein - zinc finger protein 521 (EHZF/ZNF521): a candidate regulator of diverse immature cells 38
Jagged ligands enhance the pro-angiogenic activity of multiple myeloma cells 38
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 38
Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation 37
The non-coding RNA landscape of plasma cell dyscrasias 37
Early hematopoietic zinc finger protein prevents tumor cell recognition by natural killer cells 37
Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity 36
Selective Activation of the Non-Classical Estrogen Receptor Gper Elicits Potent Anti-Tumor Activity in Multiple Myeloma 36
Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia 35
In vitro and vivo activity against multiple myeloma cells of a novel locked nucleic acid (LNA)-miR-221 inhibitor 35
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells 35
Activating E17K mutation in the gene encoding the protein kinase B/AKT in squamous cell carcinoma of the lung 35
From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario 34
miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies 34
Non-coding RNA: A novel opportunity for the personalized treatment of multiple myeloma 34
Receptor identification and physiological characterisation of glucagon-like peptide-2 in the rat heart 34
In vitro expansion of tumour cells derived from blood and tumour tissue is useful to redefine personalized treatment in non-small cell lung cancer patients 34
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma 34
Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myeloma. 34
Biological Insights into Myeloma and Other B Cell Malignancies 34
The chromogranin A1-373 fragment reveals how a single change in the protein sequence exerts strong cardioregulatory effects by engaging neuropilin-1 33
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: In vitro and in vivo anti-tumor activity 32
Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth 32
SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells. 32
Early Hematopoietic Zinc Finger (EHZF/ZNF521) prevents tumor cell recognition by Natural Killer Cells 32
Circulating biomarkers in osteosarcoma: new translational tools for diagnosis and treatment. 32
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity 32
Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma 31
A Comparison of Different Sample Processing Protocols for MALDI Imaging Mass Spectrometry Analysis of Formalin-Fixed Multiple Myeloma Cells 30
Mouse Models as a Translational Platform for the Development of New Therapeutic Agents in Multiple Myeloma 30
Arginine Methylation Mediated By PRMT5 Has Significant Biological and Clinical Impact in Multiple Myeloma 30
Phoenixin-14: detection and novel physiological implications in cardiac modulation and cardioprotection 30
Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients 29
Early Hematopoietic Zinc Finger protein (EHZF), a novel co-transcription factor: functional properties, expression in myelogenous leukaemias and interactions with histone deacetylases 29
miR-22 suppresses DNA ligase III addiction in multiple myeloma. 29
Chromofungin, CgA47-66-derived peptide, produces basal cardiac effects and postconditioning cardioprotective action during ischemia/reperfusion injury 29
ZINC FINGER PROTEIN 521 (EHZF/ZNF521) ANTAGONIZES EARLY B-CELL FACTOR 1 AND MODULATES THE B-LYMPHOID DIFFERENTIATION OF PRIMARY HEMATOPOIETIC PROGENITORS 28
Functional Analysis of microRNA in Multiple Myeloma 27
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence 27
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 27
Current status and future perspectives on therapeutic potential of apigenin: Focus on metabolic-syndrome-dependent organ dysfunction 27
Contribution of PKB/AKT signaling to thyroid cancer 26
Tumor Suppressor MiR-29b Targets HDAC4 and Modulates Vorinostat Activity In Multiple Myeloma Cells 26
Natural Agents as Novel Potential Source of Proteasome Inhibitors with Anti-Tumor Activity: Focus on Multiple Myeloma 25
MiR-29b Exerts Anti-Multiple Myeloma Activity by Targeting Key Oncogenic Pathways and Modulating DNA Methylation Profile 25
Two red wine flavonoids, quercetin and myricetin, exert different myocardial and coronary actions through distinct intracellular pathways 25
Totale 4.093
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.392
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.392
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021301 0 0 0 14 34 21 20 14 54 45 72 27
2021/2022569 23 2 5 154 38 13 24 113 54 61 71 11
2022/20231.183 386 64 71 68 100 93 5 87 163 51 70 25
2023/2024515 113 73 34 42 28 129 13 8 2 14 19 40
2024/20252.129 321 95 65 58 151 302 44 51 266 130 214 432
2025/20261.280 264 494 445 77 0 0 0 0 0 0 0 0
Totale 6.256